Zehbe I - Search Results

1

p53 mutations are common in human papillomavirus type 38-positive non-melanoma skin cancers.

Caldeira S, Filotico R, Accardi R, Zehbe I, Franceschi S, Tommasino M. Caldeira S, et al. Among authors: zehbe i. Cancer Lett. 2004 Jun 8;209(1):119-24. doi: 10.1016/j.canlet.2003.12.003. Cancer Lett. 2004. PMID: 15145527

2

The E6 and E7 proteins of the cutaneous human papillomavirus type 38 display transforming properties.

Caldeira S, Zehbe I, Accardi R, Malanchi I, Dong W, Giarrè M, de Villiers EM, Filotico R, Boukamp P, Tommasino M. Caldeira S, et al. Among authors: zehbe i. J Virol. 2003 Feb;77(3):2195-206. doi: 10.1128/jvi.77.3.2195-2206.2003. J Virol. 2003. PMID: 12525654 Free PMC article.

3

The role of TP53 in Cervical carcinogenesis.

Tommasino M, Accardi R, Caldeira S, Dong W, Malanchi I, Smet A, Zehbe I. Tommasino M, et al. Among authors: zehbe i. Hum Mutat. 2003 Mar;21(3):307-12. doi: 10.1002/humu.10178. Hum Mutat. 2003. PMID: 12619117 Review.

4

Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype.

Zehbe I, Wilander E, Delius H, Tommasino M. Zehbe I, et al. Cancer Res. 1998 Feb 15;58(4):829-33. Cancer Res. 1998. PMID: 9485042

5

p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development.

Zehbe I, Voglino G, Wilander E, Delius H, Marongiu A, Edler L, Klimek F, Andersson S, Tommasino M. Zehbe I, et al. Cancer Res. 2001 Jan 15;61(2):608-11. Cancer Res. 2001. PMID: 11212257

6

Rare human papillomavirus 16 E6 variants reveal significant oncogenic potential.

Zehbe I, Lichtig H, Westerback A, Lambert PF, Tommasino M, Sherman L. Zehbe I, et al. Mol Cancer. 2011 Jun 24;10:77. doi: 10.1186/1476-4598-10-77. Mol Cancer. 2011. PMID: 21702904 Free PMC article.

7

Variants of the long control region and the E6 oncogene in European human papillomavirus type 16 isolates: implications for cervical disease.

Kämmer C, Tommasino M, Syrjänen S, Delius H, Hebling U, Warthorst U, Pfister H, Zehbe I. Kämmer C, et al. Among authors: zehbe i. Br J Cancer. 2002 Jan 21;86(2):269-73. doi: 10.1038/sj.bjc.6600024. Br J Cancer. 2002. PMID: 11870518 Free PMC article.

8

Increased risk for cervical disease progression of French women infected with the human papillomavirus type 16 E6-350G variant.

Grodzki M, Besson G, Clavel C, Arslan A, Franceschi S, Birembaut P, Tommasino M, Zehbe I. Grodzki M, et al. Among authors: zehbe i. Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):820-2. doi: 10.1158/1055-9965.EPI-05-0864. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16614130

9

Codon 72 polymorphism of p53 and its association with cervical cancer.

Zehbe I, Voglino G, Wilander E, Genta F, Tommasino M. Zehbe I, et al. Lancet. 1999 Jul 17;354(9174):218-9. doi: 10.1016/S0140-6736(99)01914-5. Lancet. 1999. PMID: 10421306

10

Human papillomavirus 16 E6 variants differ in their dysregulation of human keratinocyte differentiation and apoptosis.

Zehbe I, Richard C, DeCarlo CA, Shai A, Lambert PF, Lichtig H, Tommasino M, Sherman L. Zehbe I, et al. Virology. 2009 Jan 5;383(1):69-77. doi: 10.1016/j.virol.2008.09.036. Epub 2008 Nov 4. Virology. 2009. PMID: 18986660 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters